Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Pollen Allergenic Extract [EPC]
Sorghum Halepense Pollen is a standardized allergenic extract used in the diagnosis and treatment of Johnsongrass-induced allergic rhinitis and asthma. It belongs to the class of Standardized Pollen Allergenic Extracts and is utilized in allergen-specific immunotherapy.
Name
Sorghum Halepense Pollen
Raw Name
SORGHUM HALEPENSE POLLEN
Category
Standardized Pollen Allergenic Extract [EPC]
Drug Count
35
Variant Count
38
Last Verified
February 17, 2026
About Sorghum Halepense Pollen
Sorghum Halepense Pollen is a standardized allergenic extract used in the diagnosis and treatment of Johnsongrass-induced allergic rhinitis and asthma. It belongs to the class of Standardized Pollen Allergenic Extracts and is utilized in allergen-specific immunotherapy.
Detailed information about Sorghum Halepense Pollen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Sorghum Halepense Pollen.
Sorghum Halepense Pollen, commonly known as Johnsongrass pollen, is a potent aeroallergen used clinically as a Standardized Pollen Allergenic Extract [EPC]. This biological product is derived from the pollen of Sorghum halepense, a perennial grass that is widely distributed across the United States and other temperate regions. In the context of clinical pharmacology, this extract is utilized for two primary purposes: the diagnostic skin testing of patients suspected of having IgE-mediated hypersensitivity to grass pollens and the therapeutic practice of allergen-specific immunotherapy (AIT), often referred to as 'allergy shots.'
As a member of the Standardized Pollen Allergenic Extract class, Sorghum Halepense Pollen is regulated by the FDA under the Center for Biologics Evaluation and Research (CBER). Unlike traditional small-molecule drugs, these extracts are complex mixtures of proteins, glycoproteins, and polysaccharides. The primary goal of using this extract in a therapeutic setting is to induce immunological tolerance in patients suffering from allergic rhinitis (hay fever), allergic conjunctivitis, and seasonal allergic asthma. By exposing the immune system to gradually increasing doses of the allergen, healthcare providers can shift the patient's immune response from a pro-inflammatory state to one of clinical desensitization.
The mechanism of action for Sorghum Halepense Pollen in immunotherapy is multifaceted and involves a fundamental reprogramming of the adaptive immune system. When a patient is allergic to Johnsongrass, their immune system incorrectly identifies the pollen proteins (such as the major allergen Sor h 1) as dangerous threats, leading to the production of allergen-specific Immunoglobulin E (IgE) antibodies. These IgE antibodies bind to mast cells and basophils. Upon subsequent exposure to the pollen, the allergen cross-links these IgE molecules, triggering the release of histamine, leukotrienes, and cytokines, which result in the classic symptoms of sneezing, itching, and airway inflammation.
Therapeutic administration of Sorghum Halepense Pollen works by reversing this process through 'desensitization.' At the molecular level, the extract stimulates the production of 'blocking antibodies,' specifically Immunoglobulin G4 (IgG4) and Immunoglobulin A (IgA). These antibodies compete with IgE for binding sites on the allergen, effectively neutralizing the pollen before it can trigger mast cell degranulation. Furthermore, the treatment induces the expansion of regulatory T cells (Tregs), which secrete anti-inflammatory cytokines like Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-β). These cytokines suppress the Th2-driven allergic response and promote a more balanced Th1-type immune profile. Over time, this leads to a significant reduction in both the immediate and late-phase allergic reactions.
Traditional pharmacokinetic parameters (Absorption, Distribution, Metabolism, and Elimination) are defined differently for allergenic extracts compared to oral or intravenous medications because the extract is a biological mixture intended for local immune interaction rather than systemic pharmacological activity.
Sorghum Halepense Pollen extracts are FDA-approved for the following indications:
Sorghum Halepense Pollen is typically available in the following forms:
> Important: Only your healthcare provider can determine if Sorghum Halepense Pollen is right for your specific condition. Immunotherapy should only be administered under the supervision of a physician prepared to treat systemic anaphylaxis.
Dosage for Sorghum Halepense Pollen is highly individualized and does not follow a 'one size fits all' approach. The treatment is divided into two distinct phases: the Build-up Phase and the Maintenance Phase.
During the initial phase, the patient receives injections once or twice weekly. The starting dose is extremely low, typically ranging from 0.05 mL to 0.1 mL of a highly diluted solution (e.g., 1:100,000 or 1:10,000 v/v). The dose is incrementally increased at each visit, provided the patient tolerates the previous dose without significant local or systemic reactions. This phase usually lasts 3 to 6 months.
Once the 'top dose' or maximum tolerated dose is reached, the frequency of injections is decreased to once every 2 to 4 weeks. A common maintenance dose may range from 0.2 mL to 0.5 mL of the most concentrated extract (e.g., 10,000 BAU/mL or 20,000 PNU/mL). Maintenance therapy is typically continued for 3 to 5 years to ensure long-lasting immunological memory.
Sorghum Halepense Pollen is generally considered safe and effective for children, typically starting at age 5. The dosing schedule for pediatric patients is similar to that of adults, though the physician may choose a more conservative build-up schedule depending on the child's sensitivity levels. It is not generally recommended for children under age 5 due to the difficulty of communicating systemic symptoms and the higher risk of respiratory distress.
No specific dosage adjustments are required for patients with renal impairment, as the extract is not cleared via the kidneys. However, the patient's overall health and ability to tolerate emergency medications (like epinephrine) must be considered.
No dosage adjustments are needed for hepatic impairment. The metabolic pathway of allergenic proteins does not involve the cytochrome P450 system.
In patients over 65, caution is advised. Healthcare providers must evaluate the patient's cardiovascular status, as elderly individuals may be less able to tolerate the physiological stress of a systemic reaction or the medications used to treat it (e.g., epinephrine).
Sorghum Halepense Pollen for immunotherapy MUST be administered by a healthcare professional in a clinical setting equipped with emergency resuscitation equipment.
If a dose is missed during the build-up phase, the next dose may need to be reduced or the previous dose repeated to maintain safety. If several weeks are missed during the maintenance phase, the physician may need to 'back up' the dosage to a lower concentration and gradually build back up to the maintenance level. Never attempt to 'double up' on doses to make up for a missed one.
An 'overdose' in the context of immunotherapy usually refers to an accidental administration of a concentration higher than intended or a dose that exceeds the patient's current tolerance level. Signs of overdose include immediate systemic reactions such as generalized hives, swelling of the throat, wheezing, and drop in blood pressure. Emergency treatment with epinephrine is required immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Ensure you inform your doctor of any new medications or changes in your health before receiving an injection.
Most patients receiving Sorghum Halepense Pollen immunotherapy will experience some form of local reaction. These are generally considered a normal part of the immune system's response to the allergen.
> Warning: Stop taking Sorghum Halepense Pollen and call your doctor immediately or seek emergency care if you experience any of these symptoms of anaphylaxis.
There are no known long-term 'toxic' side effects associated with Sorghum Halepense Pollen, as it is a natural protein extract. The most significant long-term 'effect' is the desired change in the immune system. However, patients should be monitored for the development of 'eosinophilic esophagitis' (EoE), a rare inflammatory condition of the esophagus that has been occasionally linked to sublingual forms of immunotherapy, though it is less common with the injectable form of Sorghum Halepense Pollen.
Standardized allergenic extracts, including Sorghum Halepense Pollen, carry an FDA-mandated warning regarding the risk of severe systemic reactions.
Summary of Warning: Sorghum Halepense Pollen can cause severe life-threatening systemic reactions, including anaphylaxis. Patients with unstable or severe asthma are at higher risk for fatal reactions. Immunotherapy should only be administered in a setting where trained personnel and equipment for emergency resuscitation are available. Patients should be observed for at least 30 minutes following administration. Patients taking beta-blockers may be resistant to the effects of epinephrine, which is the primary treatment for anaphylaxis.
Report any unusual symptoms to your healthcare provider, even if they seem minor at first. Early recognition of a systemic reaction is critical for safe treatment.
Sorghum Halepense Pollen is a biological product that requires strict adherence to safety protocols. It is not a medication that can be self-administered at home. Patients must be in a stable state of health before receiving each injection. If you are experiencing an asthma flare-up, have a fever, or are suffering from an acute infection, your healthcare provider will likely postpone your injection to avoid the risk of a severe reaction.
No FDA black box warnings for Sorghum Halepense Pollen are currently listed in the same format as high-risk pharmaceuticals like opioids; however, all allergenic extracts carry a prominent 'Warning' section in their prescribing information that functions similarly. This warning emphasizes that the extract can cause anaphylactic shock and death. It mandates that the product only be used by physicians experienced in the treatment of allergic diseases.
While routine blood work (like liver or kidney tests) is not necessary for Sorghum Halepense Pollen, clinical monitoring is intensive:
Most patients can drive after their 30-minute observation period. However, if you experience a systemic reaction or feel lightheaded/fatigued after your injection, you should avoid driving or operating heavy machinery until the symptoms have completely resolved.
There is no direct chemical interaction between alcohol and Sorghum Halepense Pollen. However, alcohol can cause vasodilation (widening of blood vessels), which may theoretically increase the speed of allergen absorption or mask the early symptoms of an allergic reaction. It is generally advised to avoid alcohol for several hours before and after your injection.
Stopping Sorghum Halepense Pollen suddenly does not cause a 'withdrawal' syndrome. However, the benefits of the treatment may be lost if the maintenance phase is not completed (usually 3-5 years). If you stop treatment prematurely, your allergy symptoms will likely return during the next Johnsongrass pollination season.
> Important: Discuss all your medical conditions with your healthcare provider before starting Sorghum Halepense Pollen, especially any heart or lung conditions.
There are few absolute contraindications for drug combinations, but the following are highly discouraged:
Most interactions with Sorghum Halepense Pollen are pharmacodynamic rather than pharmacokinetic. This means the drugs do not change the concentration of the pollen in the blood, but they change how the body responds to the pollen or how the body responds to the treatment for a reaction. For example, beta-blockers occupy the receptors that epinephrine needs to bind to, creating a management strategy challenge where the physician must either switch the blood pressure medication or use alternative emergency protocols (like glucagon).
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter allergy medications.
Sorghum Halepense Pollen must NEVER be used in the following circumstances:
These conditions require a careful risk-benefit analysis by the allergist:
Sorghum Halepense is a member of the Poaceae (grass) family. Patients allergic to Johnsongrass often show cross-reactivity with other grasses, particularly those in the Panicoideae subfamily. This includes:
If you have had a severe reaction to any of these grasses, you may be more likely to react strongly to Sorghum Halepense Pollen.
> Important: Your healthcare provider will evaluate your complete medical history, including your respiratory function and cardiovascular health, before prescribing Sorghum Halepense Pollen.
Pregnancy Category: C (According to traditional FDA labeling).
It is not known whether Sorghum Halepense Pollen allergenic components or the antibodies produced by the mother are excreted in human milk. However, since the extract is a protein that is degraded in the mother's body, it is generally considered safe to continue maintenance immunotherapy while breastfeeding. The risk-benefit consideration should focus on the mother's allergic control.
No dose adjustments are necessary for patients with kidney disease. The proteins in the extract are not cleared by the kidneys, and there is no evidence of nephrotoxicity.
No dose adjustments are necessary for patients with liver disease. The metabolism of the allergen is localized and proteolytic, not involving hepatic enzyme pathways.
> Important: Special populations require individualized medical assessment. Always inform your allergist if you become pregnant or develop new health conditions during the course of your treatment.
Sorghum Halepense Pollen extract acts as an immunomodulator. Its primary molecular target is the T-cell receptor (TCR) on naive T-cells. By presenting Johnsongrass allergens in a controlled, subcutaneous environment, the extract promotes the differentiation of T-regulatory (Treg) cells. These cells produce IL-10, which has several effects:
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous/Local) |
| Protein Binding | Minimal (Local interaction) |
| Half-life | Hours (Proteins), Years (Immune memory) |
| Tmax | 15-30 minutes (Systemic absorption risk) |
| Metabolism | Local Proteolysis |
| Excretion | Lymphatic clearance |
Sorghum Halepense Pollen is classified as a Standardized Pollen Allergenic Extract [EPC]. It belongs to the broader therapeutic category of Antigen-Specific Immunotherapy. Related medications include extracts for Timothy Grass, Orchard Grass, and Kentucky Bluegrass.
Common questions about Sorghum Halepense Pollen
Sorghum Halepense Pollen extract is primarily used for the diagnosis and treatment of allergies to Johnsongrass. In diagnostic settings, it is used in skin prick tests to confirm if a patient has an IgE-mediated allergy to this specific grass. In therapeutic settings, it is used for allergen-specific immunotherapy, also known as allergy shots. This involves giving the patient gradually increasing doses of the pollen to help their immune system build a tolerance. Over time, this treatment reduces the severity of symptoms like sneezing, itchy eyes, and asthma caused by Johnsongrass exposure.
The most common side effects are local reactions at the site where the injection was given. These include redness, itching, and swelling of the skin, which can sometimes be quite large but are usually not dangerous. Some patients may also experience a temporary flare-up of their typical allergy symptoms, such as a runny nose or itchy eyes, shortly after the injection. Fatigue or a mild headache on the day of the injection are also frequently reported. While these are common, they are generally manageable and often decrease as the body adjusts to the treatment.
It is generally recommended to avoid alcohol on the days you receive your Sorghum Halepense Pollen injections. Alcohol can cause your blood vessels to dilate, which might theoretically increase the speed at which the allergen is absorbed into your bloodstream, potentially increasing the risk of a systemic reaction. Additionally, being under the influence of alcohol can make it harder for you to notice the early, subtle signs of a serious allergic reaction. Alcohol can also interfere with the medications used to treat anaphylaxis if one were to occur. Always consult your allergist for their specific policy regarding alcohol and your treatment plan.
Sorghum Halepense Pollen is generally not started during pregnancy due to the risk of a severe allergic reaction (anaphylaxis), which could be dangerous for both the mother and the developing fetus. However, if a woman is already on a stable maintenance dose and is tolerating the injections well, many allergists will allow her to continue the treatment throughout pregnancy. The dose is typically kept the same and not increased during this time. The decision to continue must be made after a thorough discussion between the patient, their allergist, and their obstetrician. Safety is the priority, as uncontrolled asthma during pregnancy also carries significant risks.
Allergen immunotherapy with Sorghum Halepense Pollen is a long-term commitment and does not provide instant relief. Most patients begin to notice a decrease in their allergy symptoms after they reach the maintenance phase of treatment, which usually takes 3 to 6 months of weekly injections. Significant improvement is typically seen after the first full grass pollen season while on the maintenance dose. For the best and most long-lasting results, the treatment is usually continued for 3 to 5 years. This duration helps ensure that the immune system remains desensitized even after the injections are stopped.
Yes, you can stop taking Sorghum Halepense Pollen injections suddenly without experiencing any physical withdrawal symptoms, as it is not an addictive medication. However, stopping the treatment before the recommended 3-to-5-year course is finished will likely result in the return of your allergy symptoms over time. The 'immune tolerance' built up during the treatment may fade if the course is not completed. If you need to stop due to side effects or lifestyle changes, you should discuss this with your allergist. They can help you determine the best way to transition off the therapy or adjust the schedule to better suit your needs.
If you miss a dose of your Sorghum Halepense Pollen immunotherapy, you should contact your allergist's office as soon as possible to reschedule. Do not try to make up for the missed dose by taking a higher dose later. Depending on how many weeks have passed since your last injection, your doctor may need to repeat your last dose or even reduce the dose slightly for safety reasons. This is especially important during the 'build-up' phase when your body is still becoming accustomed to the allergen. Consistency is key to both the safety and effectiveness of the treatment.
There is no scientific evidence to suggest that Sorghum Halepense Pollen extracts cause weight gain. The extract consists of natural proteins and a small amount of saline or glycerin, none of which have metabolic effects that would lead to increased body fat. If you experience weight changes while on immunotherapy, it is likely due to other factors such as lifestyle changes, other medications (like oral steroids sometimes used for asthma), or unrelated medical conditions. If you have concerns about your weight, you should discuss them with your primary care physician to identify the underlying cause.
Sorghum Halepense Pollen can be taken alongside most common medications, but there are some very important exceptions. You must inform your doctor if you are taking beta-blockers, ACE inhibitors, or MAO inhibitors, as these can make allergic reactions more dangerous or harder to treat. Most other allergy medications, like antihistamines and nasal sprays, can be continued and may even help reduce the local side effects of the injections. However, your doctor needs a complete list of all your supplements and prescriptions to ensure there are no hidden risks. Always update your allergist if you start a new medication during your course of treatment.
Sorghum Halepense Pollen is a biological product rather than a chemical drug, so the term 'generic' does not apply in the traditional sense. Instead, various manufacturers produce their own versions of Johnsongrass pollen extracts. While these extracts are all standardized to meet FDA requirements for potency (measured in BAU or PNU), they are not considered exactly identical or interchangeable. For this reason, allergists usually prefer to keep a patient on the same manufacturer's extract throughout their treatment. If a switch is necessary, the doctor will often reduce the dose temporarily to ensure the patient's safety with the new formulation.